|
|
|
Volumn 21, Issue 8, 2011, Pages 1217-1222
|
|
[Treatment of bone metastasis with anti-RANKL antibody].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENOSUMAB;
MONOCLONAL ANTIBODY;
OSTEOCLAST DIFFERENTIATION FACTOR;
BONE TUMOR;
BREAST TUMOR;
FEMALE;
GENETICS;
HUMAN;
IMMUNOLOGY;
MALE;
METASTASIS;
MOLECULARLY TARGETED THERAPY;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
PHYSIOLOGY;
PROSTATE TUMOR;
REVIEW;
ANTIBODIES, MONOCLONAL;
BONE NEOPLASMS;
BREAST NEOPLASMS;
CLINICAL TRIALS, PHASE III AS TOPIC;
FEMALE;
HUMANS;
MALE;
MOLECULAR TARGETED THERAPY;
PROSTATIC NEOPLASMS;
RANK LIGAND;
|
|
EID: 80054833916
PISSN: 09175857
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
